Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Apr;41(4):700–708. doi: 10.1111/j.1476-5381.1971.tb07078.x

Importance of noradrenaline found in a functional pool in maintaining spontaneous locomotor activity in rats

Chan, Onn-Leng, R A Webster
PMCID: PMC1702765  PMID: 5579467

Abstract

1. Spontaneous locomotor activity (activity) in male Wistar rats was compared with the concentrations of brain noradrenaline (NA), dopamine (DA) and metaraminol.

2. α-Methyl-m-tyrosine (αMMT) (400 mg/kg) reduced the concentrations of DA as well as NA but activity remained high in the presence of metaraminol formed from the αMMT. When tetrabenazine (TBZ) was given after αMMT pretreatment there was a fall in the levels of activity and in the concentrations of NA, DA and metaraminol.

3. α-Methyl-p-tyrosine (αMT) produced a fall in activity which was correlated with falls in the concentrations of NA and DA. 5-Hydroxytryptamine (5-HT) did not appear to be affected.

4. After depletion of NA and DA by αMT and TBZ, administration of L-dopa produced a return in activity which was significantly correlated with the concentration of NA but not DA. When αMMT was given to a similar group of pretreated animals there was no recovery of activity despite high concentrations of DA and metaraminol.

5. The dopamine β hydroxylase inhibitor, diethyldithiocarbamate (DDC), suppressed activity as well as the concentrations of NA and DA at high doses (750 mg/kg) but smaller doses (400 mg/kg) plus L-dopa gave high DA concentrations without activity.

6. It is concluded that NA and not DA is associated with activity but that it is only part of the total NA which is in the biosynthetic storage granule affected by drugs like αMT and TBZ, which controls activity. Drugs that do not affect this pool may lower NA concentrations but not reduce activity.

7. The replacement of NA by metaraminol in this functional pool does not restore activity.

Full text

PDF
700

Images in this article

703FIG. 2
on p.703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDEN N. E. ON THE MECHANISM OF NORADRENALINE DEPLETION BY ALPHA-METHYL METATYROSINE AND METARAMINOL. Acta Pharmacol Toxicol (Copenh) 1964;21:260–271. [PubMed] [Google Scholar]
  2. CARLSSON A., DAHLSTROEM A., FUXE K., HILLARP N. A. FAILURE OF RESERPINE TO DEPLETE NORADRENALINE NEURONS OF ALPHA-METHYLNORADRENALINE FORMED FROM ALPHA-METHYL DOPA. Acta Pharmacol Toxicol (Copenh) 1965;22:270–276. doi: 10.1111/j.1600-0773.1965.tb01822.x. [DOI] [PubMed] [Google Scholar]
  3. Carlsson A., Lindqvist M. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine. Eur J Pharmacol. 1967 Dec;2(3):187–192. doi: 10.1016/0014-2999(67)90085-4. [DOI] [PubMed] [Google Scholar]
  4. Chan O. L., Webster R. A. Effect of tetrabenazine and alpha-methyl-m-tyrosine on exploratory activity and brain catecholamines in rats. Br J Pharmacol. 1971 Apr;41(4):691–699. doi: 10.1111/j.1476-5381.1971.tb07077.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Corrodi H., Fuxe K., Hökfelt T. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase. Life Sci. 1966 Apr;5(7):605–611. doi: 10.1016/0024-3205(66)90291-8. [DOI] [PubMed] [Google Scholar]
  6. HAEGGENDAL J., LINGVIST M. DISCLOSURE OF LABILE MONOAMINE FRACTIONS IN BRAIN AND THEIR CORRELATION TO BEHAVIOUR. Acta Physiol Scand. 1964 Apr;60:351–357. doi: 10.1111/j.1748-1716.1964.tb02897.x. [DOI] [PubMed] [Google Scholar]
  7. HAGGENDAL J., LINDQVIST M. Behavior and monoamine levels during long-term administration of reserpine to rabbits. Acta Physiol Scand. 1963 Apr;57:431–436. doi: 10.1111/j.1748-1716.1963.tb02605.x. [DOI] [PubMed] [Google Scholar]
  8. Hanson L. C. The disruption of conditioned avoidance response following selective depletion of brain catechol amines. Psychopharmacologia. 1965 Jul 28;8(2):100–110. doi: 10.1007/BF00404170. [DOI] [PubMed] [Google Scholar]
  9. Häggendal J., Lindqvist M., Roos B. E. Further studies on monoamine metabolism and behaviour in rabbits chronically treated with reserpine. Acta Physiol Scand. 1967 Jan-Feb;69(1):95–101. doi: 10.1111/j.1748-1716.1967.tb03494.x. [DOI] [PubMed] [Google Scholar]
  10. Kopin I. J. False adrenergic transmitters. Annu Rev Pharmacol. 1968;8:377–394. doi: 10.1146/annurev.pa.08.040168.002113. [DOI] [PubMed] [Google Scholar]
  11. Moore K. E., Rech R. H. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression. J Pharmacol Exp Ther. 1967 Apr;156(1):70–75. [PubMed] [Google Scholar]
  12. Randrup A., Munkvad I. Brain dopamine and amphetamine-induced stereotyped behaviour. Acta Pharmacol Toxicol (Copenh) 1967;25(Suppl):62–62. doi: 10.1111/j.1600-0773.1967.tb03049.x. [DOI] [PubMed] [Google Scholar]
  13. Rech R. H., Borys H. K., Moore K. E. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine. J Pharmacol Exp Ther. 1966 Sep;153(3):412–419. [PubMed] [Google Scholar]
  14. Rech R. H., Carr L. A., Moore K. E. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines. J Pharmacol Exp Ther. 1968 Apr;160(2):326–335. [PubMed] [Google Scholar]
  15. SHORE P. A., ALPERS H. S. FLUOROMETRIC ESTIMATION OF METARAMINOL AND RELATED COMPOUNDS. Life Sci. 1964 Jun;3:551–554. doi: 10.1016/0024-3205(64)90165-1. [DOI] [PubMed] [Google Scholar]
  16. Weissman A., Koe B. K., Tenen S. S. Antiamphetamine effects following inhibition of tyrosine hydroxylase. J Pharmacol Exp Ther. 1966 Mar;151(3):339–352. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES